Prudential Financial
IBIO icon

Prudential Financial’s iBio IBIO Stock Holding History

Prudential Financial’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-24
Closed -$5K – 2708
2022
Q1 		$5K Hold
24
– – ﹤0.01% 2602
2021
Q4 		$7K Sell
24
-3
-11% -$1.14K ﹤0.01% 2623
2021
Q3 		$14K Buy
27
+2
+8% +$1.25K ﹤0.01% 2580
2021
Q2 		$19K Sell
25
-1
-4% -$729 ﹤0.01% 2539
2021
Q1 		$20K Buy
26
+3
+13% +$2.61K ﹤0.01% 2479
2020
Q4 		$12K Buy
+23
New +$18.7K ﹤0.01% 2442

Other funds holding IBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Prudential Financial's IBIO Position: Q2 2022 in Review

Prudential Financial sold out of iBio (IBIO) in Q2 2022, closing a stake of 24 shares — an estimated $5K sold.

Prudential Financial first reported a position in IBIO in Q4 2020 and held it in 6 quarters. The position peaked at $20K in Q1 2021. 53 funds tracked by Wall St. Rank hold IBIO as of Q2 2022.

  • Prudential Financial reported no remaining iBio position as of Q2 2022 after selling out during the quarter.
  • Prudential Financial sold 24 iBio shares in Q2 2022, an estimated $5K.
  • Prudential Financial first reported a position in iBio in Q4 2020 and held it in 6 quarters.
  • Prudential Financial's iBio position peaked at $20K in Q1 2021.
  • 53 funds tracked by Wall St. Rank held iBio as of Q2 2022.

Based on Prudential Financial's 13F filing for Q2 2022, filed 15 Aug 2022.